Diabetes mellitus is a group of metabolic diseases characterised by prolonged hyperglycaemia due to insufficient insulin production or an inadequate cellular response to the insulin produced. Oxidative changes are among the key factors in the pathophysiology of type 2 diabetes and its complications. Reactive oxygen species contribute to insulin resistance, cause damage to pancreatic beta-cells and lead to chronic inflammation. The development, progression and complications of the disease are closely related to increased radical production and reduced antioxidant defences. For this reason, many studies have investigated the impact of taking vitamin C, as one of the most potent antioxidants, to improve glycemic control and reduce insulin resistance. We systematically reviewed all available randomised trials that investigated the role of vitamin C in the management of type 2 diabetes. Based on the results obtained from the studies, we wanted to determine whether vitamin C supplementation affects insulin resistance, blood glucose levels and glycated haemoglobin levels. A search of PubMed, Web of Science and Google Scholar databases found a total of 757 studies, 19 of which were included in our systematic review. We evaluated the quality of the selected studies, extracted the basic data for each study with a short summary, then analysed and compared them with each other. The results showed that vitamin C supplementation has the potential to improve glycaemic control and insulin sensitivity in patients with type 2 diabetes by significantly lowering blood glucose, glycated haemoglobin and fasting insulin levels. Improvement was particularly evident with doses of vitamin C greater than or equal to 1000 mg, with a duration of therapy of at least 12 weeks and with concomitant antidiabetic treatment. The results of the included studies and our findings raise the possibility of including vitamin C as an adjunctive therapy in the management of type 2 diabetes, insulin resistance, and thus in improving the quality of life of patients with type 2 diabetes. However, despite the promising results, further high quality research in this area is needed to confirm our findings.
|